Pharvaris (PHVS) Exchange Rate Effect (2025 - 2026)

Pharvaris posted quarterly Exchange Rate Effect of $4.9 million for Q1 2026, up 183.79% year-on-year from $1.7 million in Q1 2025, and up 183.79% on a QoQ basis from -$5.8 million in Q1 2025.

Pharvaris (PHVS) has 2 years of Exchange Rate Effect data on file, last reported at $4.9 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.60 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -2.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -40.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -900,000.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -7.06 Mn
10 Pharvaris 267.74 Mn -73.74 Mn - 4.87 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.87 Mn
Mar 31, 2026 4.87 Mn
Mar 31, 2025 -5.81 Mn
Mar 31, 2025 -5.81 Mn